Search Results
Mar 26, 2026, 09:00 ET GigaMedia Announces Fourth-Quarter and Full Year 2025 Financial Results
enhancing our product developing sophistication for further expanding our product and service offerings. We believe in-house developing capability is very essential in boosting our productivity and accelerating the growth of our business.Fourth Quarter and Full Year Overview Consolidated
More news about: GigaMedia
Mar 26, 2026, 08:53 ET New Book Provides an Essential Roadmap to a Successful Business Exit
their companies, build leverage, and achieve stronger outcomes when they sell."Most business owners spend decades building their company but very little time learning how to sell it," said Tim Vorhoff. "This book is meant to change that by giving owners a clear understanding of the process so
More news about: Tim Vorhoff
Mar 26, 2026, 08:47 ET Lou Antonucci Sets Harry Chapin's Words to Music for the First Time in "Singing My Songs Alone"
offers a gentle sense of resolution: "When the stagehands finally dim the lights, I'll be bringing my songs back home.""My dad wrote from a very honest place, and Lou clearly approached this with that same respect," said Jason Chapin. "It's powerful to hear those words reach people in a new musical
More news about: Lou Antonucci
Mar 26, 2026, 08:44 ET Fabrix.ai Named in Multiple Gartner® Agentic AI Reports Across AI SRE, Observability, CSP Assurance, IT Operations & Emerging Tech Categories
operations.Emerging Tech Impact Radar: India (October 2025) Fabrix.ai is one of only seven vendors recognized in the Agentic AI category, rated "Very High" mass impact with a 3-to-6-year adoption horizon. This sixth Gartner inclusion reinforces Fabrix.ai's legitimacy in a market where Gartner warns
More news about: Fabrix.ai
Mar 26, 2026, 08:36 ET IREX Announces Steve Carey, Christopher Chibwana, and Jeff Krilla Appointed to Board of Governors
rebuilding following the Maui wildfires."Our Board is evolving—and that's intentional," stated Aleksander Dardeli, president and CEO of IREX. "I'm very pleased to welcome three new members who bring perspectives we need right now: strong connections to Africa and the communities we serve, real experience
More news about: IREX
Mar 26, 2026, 08:32 ET Morphy's to Capitalize on the Continued Popularity of Marble-Collection With a 478-Lot Premier Marbles Auction on April 11
estimate is $20,000-$25,000.The second is an equally-scarce pink opaque lutz marble with red bands. The 7/8-inch-diameter marble, graded 9.7, is very hard to find in this color combination. It should realize $20,000-$25,000.The third is a shrunken core onionskin marble with colors of white,
More news about: Morphy Auctions
Mar 26, 2026, 08:30 ET Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
and they do not have another obvious cause: high fever, stiff muscles, problems thinking, irregular pulse or blood pressure, increased sweating, or very fast or uneven heartbeat.Parkinson-like symptoms. Symptoms include: body stiffness, drooling, trouble moving or walking, trouble keeping
More news about: Neurocrine Biosciences, Inc.
Mar 26, 2026, 08:11 ET Global Times: China hosts multiple key forums, spotlighting co-op, opening-up, to inject stability in an uncertain world
(MayCham China), came to this forum for the first time, and he was already impressed by some of the technology advancement here in China."I'm very interested in AI and biotechnology where China already holds a leading edge in these fields, and I'm also looking to learn more about Chinese technology
More news about: Global Times
Mar 26, 2026, 08:00 ET Merck Manuals: What Parents Need to Know About Kawasaki Disease
symptoms).After five days of fever, in most cases, the doctor will recommend that the child be seen by a health care professional. In general, pediatricians are very familiar with Kawasaki disease. They'll know what symptoms to look for and be able to recommend the right next steps.To read more of Mehta's
More news about: The Merck Manuals
Mar 26, 2026, 08:00 ET Why a Small Facility in Ohio Is Central to America's Rare Earth Supply Chain
integrated into a program, switching can be a technical and regulatory undertaking that nobody takes on lightly.That creates a competitive dynamic very different from most markets. The companies that get qualified first tend to stay qualified, because defense platforms are designed to operate for decades,
More news about: OilPrice.com
Mar 26, 2026, 07:30 ET Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trials
pipeline reflects the strength of this approach and positions us to advance a new generation of oral peptide medicines for chronic diseases.""We are very excited about the future of oral peptide therapeutics, and Pinnacle Medicines is emerging as a leader in this field," said Cindy Xiong, Partner at Foresite
More news about: Pinnacle Medicines
Mar 26, 2026, 07:30 ET Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
patient began the study with a punctuated skin ulcer and this also resolved during the 4-week treatment with SGX945. Skin ulcers are generally considered very difficult to resolve and usually require protracted treatment. Notably, some patients also explicitly reported experiencing fewer ulcers and less pain
More news about: SOLIGENIX, INC.
Mar 26, 2026, 07:05 ET Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735
adrenomyeloneuropathy (AMN) form of X-ALD, VK0214 was shown to be safe and well-tolerated, while driving significant reductions in plasma levels of very long-chain fatty acids (VLCFAs) and other lipids, as compared to placebo.For more information about Viking Therapeutics, please visit
More news about: Viking Therapeutics, Inc.
Mar 26, 2026, 07:00 ET Freightos Executes Cost Optimization Plan to Support Path to Profitability
our customers and our mission," said Pablo Pinillos, who was recently appointed Chief Executive Officer of Freightos. "These types of decisions are very difficult, but this is a necessary step to ensure Freightos is positioned for long-term, sustainable growth in a dynamic market. We believe we are exceptionally
More news about: Freightos
Mar 26, 2026, 07:00 ET BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
and advance innovative drugs to treat diseases with significant unmet needs," stated Philip Serlin, Chief Executive Officer of BioLineRx. "GLIX1 has a very compelling profile supporting this Phase 1/2a study and, to that end, we look forward to initial data in the first half of 2027." Dr. Alexandra
More news about: BioLineRx Ltd.
Mar 26, 2026, 06:59 ET Modular Flooring Market worth $16.48 billion by 2031 - Exclusive Report by MarketsandMarkets™
industrial and commercial spaces. LVTs possess a unique combination of high wear resistance, moisture resistance, and dimensional stability, making them very well-suited for extremely high-traffic settings (offices, retail chains, and hospitals). LVTs are also capable of closely imitating natural products
More news about: MarketsandMarkets
Mar 26, 2026, 06:10 ET Inadev Appoints Paul Matteucci as a Federal Partner to Lead Regulatory Agencies Portfolio and Accelerate Growth
Administration (NASA), and General Services Administration (GSA), National Center for Missing and Exploited Children (NCMEC) among others."I am very excited to join Inadev at such a pivotal moment in its growth," said Paul Matteucci. "The company's focus on Ceebit, its Agentic AI Modernization and
More news about: Inadev
Mar 26, 2026, 06:00 ET Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
real-world patient medication use, and patients benefited equally from Zenkuda treatment regardless of concomitant use," continued Dr. Wykoff."We are very pleased to see that GLOW2 demonstrated a high degree of internal consistency across all datapoints (See Figure 7, 8 and 9). Importantly,
More news about: Kodiak Sciences Inc.
Mar 26, 2026, 06:00 ET BRP PRESENTS ITS FOURTH QUARTER AND FULL-YEAR 2026 RESULTS
appropriate for other purposes; readers should not place undue reliance on forward-looking statements contained herein. Forward-looking statements, by their very nature, involve inherent risks and uncertainties and are based on a number of assumptions, both general and specific. The Company cautions that its
More news about: BRP Inc.
Mar 26, 2026, 05:40 ET Ericsson to expand and modernize SoftBank Corp.'s core network in Japan
customers while driving innovation in the telecom industry."Jawad Mansour, President and Representative Director of Ericsson Japan, says: "We are very pleased that SoftBank, an industry frontrunner in merging AI with telecommunications, has selected our core network and IMS solutions to underpin its
More news about: Ericsson
Mar 26, 2026, 05:37 ET Ericsson to expand and modernize SoftBank Corp.'s core network in Japan
customers while driving innovation in the telecom industry."Jawad Mansour, President and Representative Director of Ericsson Japan, says: "We are very pleased that SoftBank, an industry frontrunner in merging AI with telecommunications, has selected our core network and IMS solutions to underpin its
More news about: Ericsson
Mar 26, 2026, 04:11 ET India Drone Detection Radar Market Set for Rapid Expansion, Expected to Reach USD 552 Million by 2032, Reports MarkNtel Advisors
L/S-Band, Multi-band RadarBy Platform: Ground-based, Naval, Airborne, Vehicle-mounted / PortableBy Detection Range: Very Short (<2 km), Short (2–5 km), Medium (5–10 km), Long (>10 km)By End User: Military & Defense, Homeland Security, Airports
More news about: MarkNtel Advisors
Mar 26, 2026, 04:00 ET Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC)
inflammatory reaction at the injection siteThe safety for use of JUVÉDERM® VOLUMA® XC injectable gel in patients with very thin skin in the mid-face has not been establishedThe safety of using a cannula with JUVÉDERM® VOLUMA® XC for cheek augmentation
More news about: AbbVie
Mar 26, 2026, 03:21 ET Hansa Biopharma publishes 2025 Annual and Sustainability Reports
significance (p<0.0001), demonstrating that imlifidase can enable transplantation for highly sensitized patients who otherwise face years on dialysis with very limited or no access to compatible organs. ConfIdeS is the first large, randomized trial of imlifidase and reinforces the clinical relevance of Hansa's
More news about: Hansa Biopharma AB
Mar 26, 2026, 03:19 ET Hansa Biopharma publishes 2025 Annual and Sustainability Reports
significance (p<0.0001), demonstrating that imlifidase can enable transplantation for highly sensitized patients who otherwise face years on dialysis with very limited or no access to compatible organs. ConfIdeS is the first large, randomized trial of imlifidase and reinforces the clinical relevance of Hansa's
More news about: Hansa Biopharma AB